SEC Form 4 · accession 0001437749-17-000906
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry D Hiebert
Officer — Executive Vice President
Period of report
Jan 18, 2017
Accepted (ET)
Jan 20, 2017 · 12:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 18, 2017 | M | 2,500 | $5.63 | A | 12,839 | D | |
| Common Stock | Jan 18, 2017 | F | 1,135 | $12.40 | D | 11,704 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy) | $5.63 | Jan 18, 2017 | M | 2,500 | D | May 26, 2011 | May 26, 2017 | Common Stock | 2,500 | 55,500 | D |